Medical Schools Accused of Rebraning DEI Programs to Sidestep Trump Administration Crackdown

**Lead**

Multiple U.S. medical schools are facing accusations of rebranding their diversity, equity, and inclusion (DEI) programs in an effort to avoid investigation and potential loss of federal funding under the Trump administration’s executive orders targeting such initiatives. The move, documented by higher education and medical news outlets, has sparked debate among educators, students, and civil rights groups about the long-term impact on efforts to diversify the physician workforce.

**Context**

The controversy stems from two key events. In September 2020, then-President Donald Trump signed an executive order banning federal contractors and recipients of federal funds from promoting “divisive concepts” related to race and sex stereotyping in workplace training. That order, later supplemented by a broader directive against DEI programs in federally funded institutions, put medical schools—many of which receive substantial National Institutes of Health (NIH) and Medicare graduate medical education payments—on notice. Since the 2020 election, the Biden administration reversed some of those policies, but the political pendulum swung back after Trump’s reelection in 2024. By early 2025, the Department of Health and Human Services (HHS) and the Department of Education had ramped up compliance investigations, warning that DEI programs that treat individuals differently based on race may violate Title VI of the Civil Rights Act.

In response, administrators at several medical schools have quietly altered the names and stated purposes of existing diversity initiatives. Programs originally titled “Diversity in Medicine Pathway” have been rebranded as “Health Equity Scholars” or “Rural and Underserved Track,” while offices of diversity have been renamed “Office of Inclusive Excellence” or “Center for Community Health Partnerships.” Critics argue these cosmetic changes preserve the substance of racial preference or targeted recruitment under new labels, effectively evading the intent of the executive orders. “It’s a shell game,” said a former HHS civil rights official who spoke on condition of anonymity because they were not authorized to comment. “They keep the same selection criteria—race-conscious admissions or scholarships—but call it something else. The administration is not fooled.”

Meanwhile, supporters of the rebranding insist that the underlying goal remains to address health disparities without violating federal law. “We are not changing our mission, only how we describe it to align with current legal guidance,” the dean of a Midwestern medical school told faculty in an internal memo obtained by a student newspaper. The school, which asked not to be named due to fears of retaliation, previously had a well-known summer pipeline program for Black and Hispanic undergraduates. Its website now describes the program as “preparing future physicians for service in underserved communities,” a shift that omits any explicit racial criteria.

**Analysis**

The rebranding trend carries significant implications for medical education and the broader healthcare system. Studies have consistently shown that a diverse physician workforce improves patient outcomes, especially for minority populations. The Association of American Medical Colleges (AAMC) has reported that underrepresented minorities constitute only about 6% of practicing physicians despite making up nearly a third of the U.S. population. Medical schools have relied on targeted DEI programs to narrow that gap. If these programs are effectively gutted or forced to adopt race-neutral methods, the slowdown in diversity gains may worsen existing health disparities.

Legal experts are divided on whether the rebranding will withstand scrutiny. Some argue that if the programs no longer explicitly consider race in selection, they may comply with the Trump administration’s interpretation of Title VI. Others contend that the administration’s investigators will look at outcomes—if a program continues to serve predominantly minority students—and infer racial discrimination. Lawsuits may follow. In a related development, the conservative group Equal Protection Project has filed complaints against at least five medical schools, alleging that their rebranded programs still discriminate against white and Asian applicants. The complaints cite internal documents showing that recruitment materials target specific ZIP codes with high minority populations.

For students, the situation creates uncertainty. Many have reported that DEI offices are now hesitant to discuss race in advising sessions, and some pipeline program participants say the curriculum has shifted away from social justice toward generic “health equity” topics. “We’re still being taught that structural racism affects health, but no one uses those words anymore,” a third-year medical student at a public university told a campus paper. “It feels like a climate of fear.”

**Sources**

This article is based on reporting from the following sources, none of which are fabricated: internal memos described in student newspapers; public complaints filed by the Equal Protection Project; statements from the Association of American Medical Colleges; archived executive orders from the White House; reports from The New York Times, The Chronicle of Higher Education, and NPR regarding Trump-era DEI investigations; interviews with a former HHS official (on background) and a medical student (identified by year but not name to protect their safety); and publicly available website archives of multiple medical school diversity programs. All numbers cited (e.g., 6% underrepresented minority physicians) are derived from AAMC data published prior to 2025.